Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Josh Cohen

Democrats need a midterm win in Texas to take back the Senate. Jasmine Crockett just made things interesting

NEWS ANALYSIS: Trump nemesis’ decision to run in Texas instantly shook up the race, and she faces detractors on the right and left. But some believe she could end up surprising everybody, writes John Bowden

The Independent UK

The populist playbook: Democratic US Senate candidate seeks to replicate Mamdani’s success

Abdul El-Sayed’s bid for Michigan senator centers on bold leftwing populism similar to the NYC mayoral candidate

The Guardian - US

All the Rage by Josh Cohen review – seeing red

The psychoanalyst examines how rage has become the defining colour of our social and political lives, in this strangely unsettled and unsettling work

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Face your anger and let it out. It’s the only way to stay healthy

More than sadness, hatred or grief, rage is something that we shut away or flee. That endangers our relationships, our happiness – and our safety

The Guardian - UK

Lots of drug companies talk about putting patients first — but this one actually did

When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn't work, the company took the unusual step of voluntarily pulling it off the market.

WEKU

Six Miami players hit double figures as Hurricanes beat St. Francis, 91-76, improve to 11-1

CORAL GABLES, Fla. — On paper, Saturday’s home game against St. Francis (Penn.) looked like an easy outing before the 25th-ranked Miami Hurricanes face No. 2 Virginia on Tuesday.

Miami Herald

‘If not for the Ice Bucket Challenge, we wouldn’t be here’: Cambridge company on the brink of FDA-approved ALS treatment

BOSTON — Eight years after the ALS Ice Bucket Challenge went viral across social media and raised hundreds of millions of dollars for research, a Cambridge company is on the brink of a major breakthrough for ALS patients.

Boston Herald

Read news from The Economist, FT, and more,
with one subscription

Controversial ALS drug from Amylyx gets rare second FDA meeting

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

Tribune News Service

North American players in Europe: the best XI, from Davies to Wingo

As the European calendar officially shifts to preseason, we take one final look at the best American and Canadian men’s players abroad over the past year

People

Cameron CarterVickers

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.